RPRX logo

Royalty Pharma plc (RPRX) Accounts payable

annual accounts payable:

$13.37M-$1.79M(-11.84%)
December 31, 2024

Summary

  • As of today (September 10, 2025), RPRX annual accounts payable is $13.37 million, with the most recent change of -$1.79 million (-11.84%) on December 31, 2024.
  • During the last 3 years, RPRX annual accounts payable has risen by +$7.75 million (+137.90%).
  • RPRX annual accounts payable is now -11.84% below its all-time high of $15.16 million, reached on December 31, 2023.

Performance

RPRX Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXbalance sheet metrics

quarterly accounts payable:

$20.21M-$17.42M(-46.30%)
June 30, 2025

Summary

  • As of today (September 10, 2025), RPRX quarterly accounts payable is $20.21 million, with the most recent change of -$17.42 million (-46.30%) on June 30, 2025.
  • Over the past year, RPRX quarterly accounts payable has dropped by -$3.21 million (-13.70%).
  • RPRX quarterly accounts payable is now -46.30% below its all-time high of $37.63 million, reached on March 31, 2025.

Performance

RPRX quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

RPRX Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-11.8%-13.7%
3 y3 years+137.9%+66.0%
5 y5 years+19.6%-41.2%

RPRX Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-11.8%+137.9%-46.3%+247.9%
5 y5-year-11.8%+137.9%-46.3%+259.6%
alltimeall time-11.8%>+9999.0%-46.3%+259.6%

RPRX Accounts payable History

DateAnnualQuarterly
Jun 2025
-
$20.21M(-46.3%)
Mar 2025
-
$37.63M(+181.5%)
Dec 2024
$13.37M(-11.8%)
$13.37M(-39.4%)
Sep 2024
-
$22.05M(-5.8%)
Jun 2024
-
$23.42M(+102.7%)
Mar 2024
-
$11.55M(-23.8%)
Dec 2023
$15.16M(+91.8%)
$15.16M(+11.3%)
Sep 2023
-
$13.63M(+134.6%)
Jun 2023
-
$5.81M(-12.7%)
Mar 2023
-
$6.66M(-15.8%)
Dec 2022
$7.91M
$7.91M(-50.9%)
Sep 2022
-
$16.11M(+32.3%)
Jun 2022
-
$12.18M(+82.8%)
DateAnnualQuarterly
Mar 2022
-
$6.66M(+18.5%)
Dec 2021
$5.62M(-47.8%)
$5.62M(-38.8%)
Sep 2021
-
$9.19M(-2.2%)
Jun 2021
-
$9.39M(+13.6%)
Mar 2021
-
$8.27M(-23.2%)
Dec 2020
$10.78M(-3.6%)
$10.78M(-55.8%)
Sep 2020
-
$24.39M(-29.0%)
Jun 2020
-
$34.37M(+65.6%)
Mar 2020
-
$20.75M(+85.7%)
Dec 2019
$11.18M(+149.7%)
$11.18M
Dec 2018
$4.48M(>+9900.0%)
-
Dec 2017
$0.00(0.0%)
-
Dec 2016
$0.00(0.0%)
-
Dec 2015
$0.00
-

FAQ

  • What is Royalty Pharma plc annual accounts payable?
  • What is the all time high annual accounts payable for Royalty Pharma plc?
  • What is Royalty Pharma plc annual accounts payable year-on-year change?
  • What is Royalty Pharma plc quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Royalty Pharma plc?
  • What is Royalty Pharma plc quarterly accounts payable year-on-year change?

What is Royalty Pharma plc annual accounts payable?

The current annual accounts payable of RPRX is $13.37M

What is the all time high annual accounts payable for Royalty Pharma plc?

Royalty Pharma plc all-time high annual accounts payable is $15.16M

What is Royalty Pharma plc annual accounts payable year-on-year change?

Over the past year, RPRX annual accounts payable has changed by -$1.79M (-11.84%)

What is Royalty Pharma plc quarterly accounts payable?

The current quarterly accounts payable of RPRX is $20.21M

What is the all time high quarterly accounts payable for Royalty Pharma plc?

Royalty Pharma plc all-time high quarterly accounts payable is $37.63M

What is Royalty Pharma plc quarterly accounts payable year-on-year change?

Over the past year, RPRX quarterly accounts payable has changed by -$3.21M (-13.70%)
On this page